TMDX
TMDX
NASDAQ · Health Care

Transmedics Group Inc

$88.24
+19.26 (+27.92%)
Financial Highlights (FY 2026)
Revenue
510.08M
Net Income
160.31M
Gross Margin
59.9%
Profit Margin
31.4%
Rev Growth
+86.4%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 510.08M 273.62M 2.67B 2.60B
Gross Profit 305.64M 163.95M 1.10B 1.07B
Operating Income 91.46M 44.15M 215.76M 258.19M
Net Income 160.31M 77.39M 176.17M 221.55M
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Rev Growth +86.4% +86.4% -8.6% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 783.46M 783.46M 1.93B 1.88B
Total Equity 723.35M 723.35M 2.11B 1.74B
D/E Ratio 1.08 1.08 0.92 1.08
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 91.64M 46.70M 309.48M 247.18M
Free Cash Flow — — 251.22M 206.55M